How COVID-19 Compromised U.S. Gains in Controlling HIV
The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities.
University of California San Francisco
Give to UCSFThe COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities.
New research shows that in the U.S., the longevity gap between women and men has been widening for more than a decade, with women outliving men by an average of six years.
A collaboration is between two biomedical researchers bridges the laboratory and clinic to advance the science of itch, allergy and asthma.
U.S. House Speaker Emerita Nancy Pelosi was honored at UCSF with the first ever Bay Area Global Health Alliance Leadership Award for championing policies supporting people living with AIDS/HIV throughout her career.
A phase 1 trial shows promise in treating metastatic prostate cancer with a single priming dose of radioligand therapy and immunotherapy.
UCSF's Adam Boxer, MD, PhD, and Harvard neurologist Reisa Sperling, MD, review the history of clinical trials over the past 30 years in Alzheimer’s research with what was learned and how new biomarkers and clinical trial approaches are being used to find more effective treatments in a more efficient way than in the past.
UCSF researchers developed a new neighborhood-based model of care that brings medicine to people immediately after being diagnosed with hepatitis C.
A study found that children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab.
Scientists found that the nervous system tamps down allergic response, which could change how asthma, Crohn’s and other inflammatory diseases are treated.
Suneil Koliwad weighs in on the state of insulin production after California Governor Gavin Newsom vetoed a law that would cap the price for consumers at $35 a month. California will focus instead on producing its own insulin for $30 per vial.
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers.
Recommendations are in place for the updated COVID-19 vaccine from Pfizer-BioNTech and Moderna.
The FDA recently approved the world’s first vaccines to prevent RSV for infants and elderly adults.
A new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this preventable, treatable and curable disease.
Three injectable medications, Wegovy, Ozempic and Mounjaro, are often taken as weight management drugs. UCSF health experts weigh in on the benefits and risks of taking the medications for obesity.
UCSF researchers are working across disease specialties. Diabetes researchers are looking at how oncologists use CAR T-cell therapy to reprogram a person’s immune system to attack cancer cells, for example. They hope to similarly reprogram the immune system to fight diabetes.
UCSF Benioff Children’s Hospital Oakland is the first hospital in the West to administer a newly approved gene therapy to treat beta thalassemia with gene therapy, reducing the need for lifelong blood transfusions.
Long COVID symptoms can persist for a year after initial infection, or re-emerge months later after disappearing.
UCSF Medical Center has been ranked among the country’s best hospitals in adult care in U.S. News & World Report’s prestigious Best Hospitals survey.
An experimental blood test that reflects injury to nerve cells from multiple sclerosis (MS) was found to work for children with MS and other neurological conditions, even when they are symptom-free.
Taking daily medication can be a challenge for many, leading to increased viral load over time. Injectable therapies remove that challenge.